DNA/RNA Sample Extraction and Isolation Market Report 2026

The dna/rna sample extraction and isolation market size has grown strongly in recent years. It will grow from $2.72 billion in 2025 to $2.9 billion in 2026 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to genomics research expansion, infectious disease testing growth, manual extraction limitations, laboratory standardization needs, reagent-based workflows.

The dna/rna sample extraction and isolation market size is expected to see strong growth in the next few years. It will grow to $3.71 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to automation in molecular labs, high-throughput diagnostics, biopharma r&d expansion, precision medicine workflows, laboratory efficiency optimization. Major trends in the forecast period include rising demand for high-purity genetic material, increased use in pcr and sequencing workflows, expansion of automated extraction systems, growth of research and diagnostic applications, adoption of standardized extraction kits.

The rising prevalence of infectious diseases is expected to drive the growth of the DNA/RNA sample extraction and isolation market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms, including viruses, bacteria, fungi, and parasites, which invade and multiply within the body. The increasing incidence of these diseases is fueled by urbanization, global travel, climate-driven expansion of disease vectors, and rising antimicrobial resistance. The DNA/RNA sample extraction and isolation market supports this trend by enabling sensitive molecular tests, such as PCR, that detect pathogen genetic material directly from patient samples, enhancing diagnostic accuracy and aiding in outbreak management. For example, in July 2023, the World Health Organization (WHO), a Switzerland-based UN health agency, reported that between January 1 and December 11, 2023, the Americas recorded 4.1 million suspected dengue cases (419 per 100,000 population), including 6,710 severe cases (0.16%) and 2,049 deaths (CFR 0.05%) across 42 countries, with 15 countries experiencing active outbreaks and 1,895,122 cases (45%) laboratory-confirmed by epidemiological week 48. Therefore, the rising prevalence of infectious diseases is propelling the growth of the DNA/RNA sample extraction and isolation market.

Companies in the DNA/RNA sample extraction and isolation market are increasingly adopting advanced automated sample preparation and analysis solutions to enhance workflow efficiency, improve accuracy, and support high-throughput molecular research. Automated solutions for sample preparation and analysis are technology-driven systems that mechanize critical laboratory steps, including sample disruption, purification, and nucleic acid isolation, reducing manual labor, minimizing errors, and ensuring consistent, high-quality results across diverse sample types. For instance, in November 2023, Qiagen N.V., a Germany-based biotechnology and life sciences research company, launched the TissueLyser III and the RNeasy PowerMax Soil Pro Kit to improve sample processing and RNA isolation. The TissueLyser III provides high-throughput mechanical disruption of challenging biological materials such as bone, tissue, and cells, while the RNeasy PowerMax Soil Pro Kit isolates high-purity RNA from inhibitor-rich soil samples using QIAGEN’s advanced inhibitor removal technology, enabling reliable extraction even from complex environmental matrices.

In June 2023, Merck & Co. Inc., a US-based pharmaceutical company, acquired Prometheus Biosciences Inc. for $10.8 billion. Through this acquisition, Merck aims to strengthen its strategic focus in immunology by leveraging Prometheus’s capabilities, which include DNA and RNA extraction and isolation technologies that support both therapeutic and diagnostic applications. Prometheus Biosciences Inc. is a US-based biotechnology company that provides products for DNA and RNA sample extraction and isolation.

Major companies operating in the dna/rna sample extraction and isolation market are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Danaher Corporation, MilliporeSigma, Agilent Technologies, Illumina Inc., PerkinElmer Inc., Sigma-Aldrich, Bio-Rad Laboratories Inc., Qiagen N.V., Eppendorf AG, Macherey-Nagel GmbH & Co. KG, Tecan Group, Promega Corporation, Takara Bio Inc., New England Biolabs, Omega Bio-tek Inc., Zymo Research, PCR Biosystems, Biotium Inc., Beckman Coulter, Norgen Biotek Inc.

North America was the largest region in the DNA/RNA sample extraction and isolation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna/rna sample extraction and isolation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dna/rna sample extraction and isolation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the DNA/RNA sample extraction and isolation market by increasing costs of imported extraction kits, reagents, and automated instruments. Diagnostic and research laboratories in North America and Europe are most affected due to equipment imports. These tariffs raise operational costs by increasing consumable pricing and maintenance expenses for automated extraction workflows, affecting throughput and cost-efficiency in high-volume testing environments. However, they encourage domestic manufacturing of consumables, localized production of extraction kits, and regional assembly of automation systems, supporting supply chain resilience and long-term cost optimization.

The dna/rna sample extraction and isolation market research report is one of a series of new reports that provides dna/rna sample extraction and isolation market statistics, including dna/rna sample extraction and isolation industry global market size, regional shares, competitors with a dna/rna sample extraction and isolation market share, detailed dna/rna sample extraction and isolation market segments, market trends and opportunities, and any further data you may need to thrive in the dna/rna sample extraction and isolation industry. This dna/rna sample extraction and isolation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

DNA or RNA sample extraction and isolation refer to the processes of obtaining and purifying genetic material from biological samples. These processes are critical for a variety of research applications, including genomics, transcriptomics, and molecular biology studies.

The main product types in DNA/RNA sample extraction and isolation include consumables and instruments. Consumables are the materials and reagents used and consumed during the extraction process, with kits and reagents providing the necessary chemicals and tools for isolating DNA and RNA from samples. These products are categorized by technology into consumable-based and instrument-based solutions. Applications include polymerase chain reaction (PCR), next-generation sequencing (NGS), cloning, microarray, blotting techniques, and others. End users include clinical diagnostic and forensic laboratories, academic and research institutions, pharmaceutical and biotechnology companies, contract research organizations (CROs), and others.

The DNA and RNA sample extraction and isolation market includes revenues earned by entities by high or low volume extraction solutions, buffy coat samples and related products. The market value includes the value of related goods sold by the service provider or included within the service offering. The DNA and RNA sample extraction and isolation market consists of sales of consumables such as kits and reagents, instruments, and laboratory tools used to extract or isolate DNA and or RNA molecules from various biological samples. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.